The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Precision Toxicology and Efficacy News, Insightful Insights, IVO The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Ovarian cancer is the most lethal gynecological cancer in the [...] Jack Crawford2022-02-16T09:52:11+00:00Tags: Oncology, OncoRat, drug discovery, rat model, Cancer, Hera Biolabs, oncology models, preclinical, Xenografts, gynecological Cancer, TCGA, The Cancer Genome Atlas, NSG Mice, Chemo-induced stemness, Analise DiFeo, ovarian cancer, OV81.2, OV81, Immunodeficient Rats, Cancer Xenografts, drug resistance, in vivo model, Humanized Rats, Cell Line Xenografts| Read More